Condition: Ventricular Tachycardia · Sponsor: University of Zurich
The objective of this study is to demonstrate that higher radiation doses are necessary to induce transmural scar formation which is currently assumed to be the underlying mechanism of successful long-term efficacy of VT treatment and therefore dose-escalation will lead to a significantly reduced long-term VT recurrence rate compared to the currently applied single dose of 25 Gy.
This description comes directly from the study's public registry record.
Nicolaus Andratschke, MD · 0041 44 255 4238 · nicolaus.andratschke@usz.ch
Michael Mayinger, MD · 0041 44 255 4238 · michael.mayinger@usz.ch
Always discuss trial participation with your own doctor first.
| University Hospital Ostrava | Ostrava, Czechia | Recruiting |
| University Hospital Zurich | Zurich, Canton of Zurich, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05594368